RNAi Therapeutics

Pages

▼
Showing posts with label self-delivering RNAi trigger. Show all posts
Showing posts with label self-delivering RNAi trigger. Show all posts
Thursday, May 28, 2015

RXi Pharmaceuticals Could Be Much More Than Skin Wound Healing

›
RXi Pharmaceuticals today commenced a secondary offering setting it on course to raise ~$10M, enough to finance the company for another ...
9 comments:
Wednesday, September 10, 2014

RXi Provides Disappointing Clinical Update for Scarring Drug

›
At the Rodman & Renshaw investor conference today, the CEO of RXiPharmaceuticals dropped a little bombshell in the form of a disappo...
4 comments:
Tuesday, December 3, 2013

Delivery Advance Illustrates Influence of Cosmetics Skin RNAi Therapeutics

›
The skin has always been a target organ of considerable interest to the RNAi Therapeutics industry due to its apparent accessibility for d...
2 comments:
Friday, May 31, 2013

Can RXi Pharmaceuticals Spot the Difference?

›
The imminent announcement of phase I results for RXI109 will be a clinical highlight of RNAi Therapeutics in 2013.  RXI109 is the self-d...
›
Home
View web version
Powered by Blogger.